Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody

Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease

(2017) Hironao Hozumi et al.   JOURNAL OF RHEUMATOLOGY

Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients

(2017) Youhei Fujiki et al.   Modern Rheumatology

Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody

(2017) Kentaro Isoda et al.   RHEUMATOLOGY INTERNATIONAL

Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis

(2016) Nektaria Papadopoulou-Marketou et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Radiological and Pathological Correlation in Anti-MDA5 Antibody-positive Interstitial Lung Disease: Rapidly Progressive Perilobular Opacities and Diffuse Alveolar Damage

(2016) Haruka Chino et al.   INTERNAL MEDICINE

YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer

(2015) Malvin Jefri et al.   BMC CANCER

Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis

(2015) Y. Xu et al.   CLINICAL RHEUMATOLOGY

Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue

(2015) Q.-L. Peng et al.   JOURNAL OF RHEUMATOLOGY

Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis

(2014) Takahisa Gono et al.   Modern Rheumatology

Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease

(2014) Shinji Sato et al.   Modern Rheumatology

Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis

(2014) N. Kobayashi et al.   RHEUMATOLOGY

IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis

(2014) Hidenaga Kawasumi et al.   Biomed Research International

Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease

(2013) Mizuho Nara et al.   Modern Rheumatology

Association of Interferon- and Transforming Growth Factor β-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis

(2013) Romy B. Christmann et al.   Arthritis & Rheumatology

Cellular Players in Lung Fibrosis

(2012) Annemarie N. Lekkerkerker et al.   CURRENT PHARMACEUTICAL DESIGN

The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM

(2012) T. Koga et al.   RHEUMATOLOGY

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

(2012) T. Gono et al.   RHEUMATOLOGY

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

(2011) Chun Geun Lee et al.   Annual Review of Physiology

Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis

(2011) Fang Chen et al.   RHEUMATOLOGY INTERNATIONAL

Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype

(2010) Susan K Mathai et al.   LABORATORY INVESTIGATION

Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis

(2010) Kazuki Furuhashi et al.   RESPIRATORY MEDICINE

YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease

(2008) Yongzhong Wang et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL